These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

485 related articles for article (PubMed ID: 16729326)

  • 1. Ursodeoxycholic acid exerts no beneficial effect in patients with symptomatic gallstones awaiting cholecystectomy.
    Venneman NG; Besselink MG; Keulemans YC; Vanberge-Henegouwen GP; Boermeester MA; Broeders IA; Go PM; van Erpecum KJ
    Hepatology; 2006 Jun; 43(6):1276-83. PubMed ID: 16729326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early results of combined electrohydraulic shock-wave lithotripsy and oral litholytic therapy of gallbladder stones at the University of Iowa.
    Maher JW; Summers RW; Dean TR; Swift J; Heitshusen D; Quinn G
    Surgery; 1990 Oct; 108(4):648-52; discussion 653-4. PubMed ID: 2218875
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term ursodeoxycholic acid therapy is associated with reduced risk of biliary pain and acute cholecystitis in patients with gallbladder stones: a cohort analysis.
    Tomida S; Abei M; Yamaguchi T; Matsuzaki Y; Shoda J; Tanaka N; Osuga T
    Hepatology; 1999 Jul; 30(1):6-13. PubMed ID: 10385632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ursodeoxycholic acid reduces lipid peroxidation and mucin secretagogue activity in gallbladder bile of patients with cholesterol gallstones.
    Jüngst C; Sreejayan N; Zündt B; Müller I; Spelsberg FW; Hüttl TP; Kullak-Ublick GA; del Pozo R; Jüngst D; von Ritter C
    Eur J Clin Invest; 2008 Sep; 38(9):634-9. PubMed ID: 18837739
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Results of a phase I multiple-dose clinical study of ursodeoxycholic Acid.
    Hess LM; Krutzsch MF; Guillen J; Chow HH; Einspahr J; Batta AK; Salen G; Reid ME; Earnest DL; Alberts DS
    Cancer Epidemiol Biomarkers Prev; 2004 May; 13(5):861-7. PubMed ID: 15159320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NCX-1000, a nitric oxide-releasing derivative of UDCA, does not decrease portal pressure in patients with cirrhosis: results of a randomized, double-blind, dose-escalating study.
    Berzigotti A; Bellot P; De Gottardi A; Garcia-Pagan JC; Gagnon C; Spénard J; Bosch J
    Am J Gastroenterol; 2010 May; 105(5):1094-101. PubMed ID: 19920806
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ursodeoxycholic acid treatment for patients with postcholecystectomy pain and bile microlithiasis.
    Okoro N; Patel A; Goldstein M; Narahari N; Cai Q
    Gastrointest Endosc; 2008 Jul; 68(1):69-74. PubMed ID: 18577477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Erythromycin, a motilin agonist, increases postprandial gallbladder emptying during therapy with ursodeoxycholic acid.
    Neubrand M; Sauerbruch T
    Z Gastroenterol; 1998 Apr; 36(4):267-71. PubMed ID: 9612923
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of preoperative dexamethasone in patients with laparoscopic cholecystectomy: a prospective randomized double-blind study.
    Fukami Y; Terasaki M; Okamoto Y; Sakaguchi K; Murata T; Ohkubo M; Nishimae K
    J Hepatobiliary Pancreat Surg; 2009; 16(3):367-71. PubMed ID: 19333536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biliary microlithiasis in patients with idiopathic acute pancreatitis and unexplained biliary pain: response to therapy.
    Saraswat VA; Sharma BC; Agarwal DK; Kumar R; Negi TS; Tandon RK
    J Gastroenterol Hepatol; 2004 Oct; 19(10):1206-11. PubMed ID: 15377301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Natural history of pruritus in primary biliary cirrhosis.
    Talwalkar JA; Souto E; Jorgensen RA; Lindor KD
    Clin Gastroenterol Hepatol; 2003 Jul; 1(4):297-302. PubMed ID: 15017671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Recurrence of vesicular microlithiasis. Controlled study with different dosis of ursodeoxycholic acid].
    Guma C; Viola L; Thomé M; Galdame O; Facelli A; Di Bucci A; Vaimberg D
    Medicina (B Aires); 1998; 58(5 Pt 1):474-6. PubMed ID: 9922479
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of laparoscopic cholecystectomy for biliary dyskinesia in the child.
    Kaye AJ; Jatla M; Mattei P; Kelly J; Nance ML
    J Pediatr Surg; 2008 Jun; 43(6):1057-9. PubMed ID: 18558182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized controlled trial of ursodeoxycholic acid in patients with alcohol-induced cirrhosis and jaundice.
    Pelletier G; Roulot D; Davion T; Masliah C; Causse X; Oberti F; Raabe JJ; Van Lemmens C; Labadie H; Serfaty L;
    Hepatology; 2003 Apr; 37(4):887-92. PubMed ID: 12668982
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Preventing the recurrence of common bile duct calculi following endoscopic papillotomy with ursodeoxycholic acid].
    Swobodnik W; Janowitz P; Kratzer W; Wenk H; Neuhaus H; Malfertheiner P; Hagert N; Fischer S; Ditschuneit H; Schusdziarra V
    Z Gastroenterol; 1990 Nov; 28(11):621-5. PubMed ID: 2288141
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complementary stimulation of hepatobiliary transport and detoxification systems by rifampicin and ursodeoxycholic acid in humans.
    Marschall HU; Wagner M; Zollner G; Fickert P; Diczfalusy U; Gumhold J; Silbert D; Fuchsbichler A; Benthin L; Grundström R; Gustafsson U; Sahlin S; Einarsson C; Trauner M
    Gastroenterology; 2005 Aug; 129(2):476-85. PubMed ID: 16083704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is cholecystectomy effective treatment for symptomatic gallstones? Clinical outcome after long-term follow-up.
    Gui GP; Cheruvu CV; West N; Sivaniah K; Fiennes AG
    Ann R Coll Surg Engl; 1998 Jan; 80(1):25-32. PubMed ID: 9579123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term effects of mid-dose ursodeoxycholic acid in primary biliary cirrhosis: a meta-analysis of randomized controlled trials.
    Shi J; Wu C; Lin Y; Chen YX; Zhu L; Xie WF
    Am J Gastroenterol; 2006 Jul; 101(7):1529-38. PubMed ID: 16863557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gallstone disease: Primary and secondary prevention.
    Venneman NG; van Erpecum KJ
    Best Pract Res Clin Gastroenterol; 2006; 20(6):1063-73. PubMed ID: 17127188
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gallbladder dyskinesia in acalculous biliary colic.
    Calabuig R; Castilla M; Pi F; Domingo J; Ramos L; Sierra E
    Rev Esp Enferm Dig; 1996 Nov; 88(11):770-9. PubMed ID: 9004783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.